Xtant Medical Holdings, Inc., formerly Bacterin International Holdings, Inc., is engaged in developing, manufacturing and marketing biologics products to domestic and international markets. The Company's bone graft products are used in a range of applications, including enhancing fusion in spine surgery, relief of back pain through facet joint stabilization, promotion of bone growth in foot and ankle surgery, promotion of skull healing following neurosurgery and subchondral bone repair in knee and other joint surgeries. The Company's acellular dermis scaffolds are utilized in wound care and plastic, as well as reconstructive procedures. The Company's portfolio of biologics products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoWrap, OsteoLock, BacFast HD, OsteoSTX, hMatrix, Sports Med and its line of 3Demin products, as well as other allograft products. In addition, the Company provides hardware products, including Axle, IRIX-C, Calix, Xpress and Silex.